Celsion GmbH Announces Commencement of Enrollment in Oxford University’s Phase 1 Study with ThermoDox® and Focused Ultrasound in Pancreatic Cancer LAWRENCEVILLE, N.J., July 01, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), Celsion GmbH, a wholly owned subsidiary of Celsion Corporation, a clinical-stage biotechnology company,...

CryoTherapeutics GmbH Completes an Extension to Its Series A Financing Round Bringing the Total to EUR 6.5 million COLOGNE, GERMANY--(Marketwired - May 6, 2014) - CryoTherapeutics GmbH (CryoTherapeutics), the developer of a proprietary cryotherapy system for use in the treatment of coronary artery disease,...

CryoTherapeutics GmbH Completes Second Closing of Series A Financing Round With a Total Volume of EUR 3 Million and Adds Charite Biomedical Fund as Investor COLOGNE, GERMANY--(Marketwire - Mar 21, 2013) -  CryoTherapeutics GmbH (CryoTherapeutics), the developer of a proprietary cryotherapy system for use in the treatment of coronary artery disease,...